MESSAGE FROM BMT PROGRAM DIRECTOR

The program received the JACIE accreditation in 2016, and as such became the only internationally accredited program in Lebanon and one of eight worldwide outside Europe and North America with its state-of-the art research facility and compassionate, customized care in curing patients from cancer. With this acquisition, AUBMC achieved another milestone and establishes its legacy of being an enduring medical center in Lebanon and the region.

The AUBMC BMT program saw fruition in July 2004 with the opening of a dedicated BMT unit. The program is currently the pioneering transplant program in Lebanon and is witnessing an unprecedented growth (45 transplants in 2011, 103 transplants in 2016 including 52 allogeneic BMT). It is also the first to perform unrelated donor transplant, mismatch and haplo-identical transplant in Lebanon.

Our center attracts patients from Lebanon and the region. The program also participates in transplant research and is an active member of the European (EBMT) and Eastern Mediterranean (EMBMT) Bone Marrow Transplantation groups.

Outcome results from AUBMC BMT program bench-mark with the most prestigious BMT programs in North America and Western Europe. The program received the JACIE accreditation in 2016, being the only internationally accredited program in Lebanon and one of eight worldwide outside Europe and North America.

On August 30, 2019, AUBMC celebrated a landmark achievement of crossing the 1000 bone marrow transplants since its fruition in 2004, with 80% patients being adults and 20 % being children. Results from the AUBMC BMT program benchmark with the most prestigious BMT programs in North America and Western Europe, whereby it is the first program to perform unrelated donor transplants, mismatch and haplo-identical transplants in Lebanon.

Ali Bazarbachi, MD, Ph.D.